[ET Net News Agency, 23 January 2024] KEYMED BIO-B (02162) rose 9% to HK$31.6.
It hits an intra-day high of HK$31.95, and an intra-day low of HK$29. The total shares
traded was 547,000, with a value of HK$16.62m. The active buy/sell ratio is 59:41, with
net buying turnover of HK$2.89m. MERRILL LYNCH FE accounts for greatest net responsive
buying turnover of HK$685,310, with volume weighted average price of HK$30.738. FUTU SEC
INT'L accounts for greatest net responsive selling turnover of HK$1.45m, with volume
weighted average price of HK$30.455.

Basic Information
=================

----------------------------------
Nominal 31.600 % Chg +8.97%
High 31.950 Low 29.000
Shares Tr 547,000 Turnover 16.62m
10-D SMA 37.530 %H.V 67.443
20-D SMA 41.192 VWAP 30.383
50-D SMA 48.118 RSI14 27.592
----------------------------------
Status: Active buy/sell ratio is 59:41, with net buying turnover of HK$2.89m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 31.60 +8.97
HUTCHMED (00013) 21.65 +4.09
GENSCRIPT BIO (01548) 16.16 +4.80
INNOVENT BIO (01801) 35.95 +4.81
EVEREST MED-B (01952) 18.36 +5.52
WUXI XDC (02268) 30.45 +1.16
WUXI BIO (02269) 28.65 +6.11
BEIGENE (06160) 95.55 +3.92
AKESO (09926) 42.30 +3.42
REMEGEN (09995) 22.35 +5.18
---------------------------------------------
(ed)